According to the report, the global sustained release coatings market reached a value of USD 0.53 billion in 2022. Aided by the growing demand for advanced drug delivery systems and the increased focus on improving patient compliance, the market is projected to further grow at a CAGR of 6.4% between 2023 and 2028 to reach a value of USD 0.78 billion by 2028.
Sustained release coatings are applied to pharmaceutical dosage forms, primarily tablets and capsules, to control and extend the release of a therapeutic agent over a prolonged period. This technology enhances the efficacy of medications, reduces side effects, and improves patient adherence to treatment regimens.
As per the sustained release coatings market analysis, sustained release coatings are designed to release a drug at a predetermined, predictable, and sustained rate, ensuring that the concentration of the drug remains consistent over time. These coatings are formulated using various polymers, including cellulose derivatives, acrylic polymers, and protein-based materials, which control the drug release profile by modifying the dissolution and diffusion properties of the coatings.
The controlled release of drugs from sustained release formulations results in several benefits for patients, including reduced frequency of dosing, minimised drug fluctuations in the bloodstream, improved patient compliance, and potentially fewer side effects due to more consistent drug levels.
One of the key factors propelling the global sustained release coatings market demand is the growing prevalence of chronic diseases, such as diabetes and heart disease, which often require long-term medication. These coatings are particularly beneficial for elderly patients and those with chronic conditions who may be on multiple medications and are more likely to be non-compliant with complex dosing regimens.
Additionally, sustained release coatings market growth is being fuelled by the increasing demand of these coatings in the development of novel drug delivery systems, such as multiparticulate systems, which offer further refinements in drug release profiles. These advanced systems are driving innovation in the pharmaceutical sector, pushing companies to develop more patient-friendly and effective medications.
Moreover, the rising focus on patient-centric approaches in medicine is creating a strong demand for medications that are easier to adhere to and that minimise adverse effects - characteristics that are intrinsic to sustained release formulations.
The regulatory landscape is evolving to accommodate and even encourage the development of sustained release formulations. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are actively supporting innovations in drug delivery technologies through various incentives and expedited approval pathways.
Technological advancements in coating materials and equipment are also contributing to the sustained release coatings market share. For example, the development of aqueous coating systems has addressed many of the environmental and safety issues associated with solvent-based systems, making the coating process more efficient, safer, and more sustainable.
These high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of these reports today.
The analyst always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
Sustained release coatings are applied to pharmaceutical dosage forms, primarily tablets and capsules, to control and extend the release of a therapeutic agent over a prolonged period. This technology enhances the efficacy of medications, reduces side effects, and improves patient adherence to treatment regimens.
As per the sustained release coatings market analysis, sustained release coatings are designed to release a drug at a predetermined, predictable, and sustained rate, ensuring that the concentration of the drug remains consistent over time. These coatings are formulated using various polymers, including cellulose derivatives, acrylic polymers, and protein-based materials, which control the drug release profile by modifying the dissolution and diffusion properties of the coatings.
The controlled release of drugs from sustained release formulations results in several benefits for patients, including reduced frequency of dosing, minimised drug fluctuations in the bloodstream, improved patient compliance, and potentially fewer side effects due to more consistent drug levels.
One of the key factors propelling the global sustained release coatings market demand is the growing prevalence of chronic diseases, such as diabetes and heart disease, which often require long-term medication. These coatings are particularly beneficial for elderly patients and those with chronic conditions who may be on multiple medications and are more likely to be non-compliant with complex dosing regimens.
Additionally, sustained release coatings market growth is being fuelled by the increasing demand of these coatings in the development of novel drug delivery systems, such as multiparticulate systems, which offer further refinements in drug release profiles. These advanced systems are driving innovation in the pharmaceutical sector, pushing companies to develop more patient-friendly and effective medications.
Moreover, the rising focus on patient-centric approaches in medicine is creating a strong demand for medications that are easier to adhere to and that minimise adverse effects - characteristics that are intrinsic to sustained release formulations.
The regulatory landscape is evolving to accommodate and even encourage the development of sustained release formulations. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are actively supporting innovations in drug delivery technologies through various incentives and expedited approval pathways.
Technological advancements in coating materials and equipment are also contributing to the sustained release coatings market share. For example, the development of aqueous coating systems has addressed many of the environmental and safety issues associated with solvent-based systems, making the coating process more efficient, safer, and more sustainable.
Market Segmentation
The market can be divided based on polymer material type, application, substrate, and region.Market Breakup by Polymer Material Type
- Ethyl and Methyl Cellulose
- Polyvinyl and Cellulose Acetate
- Methacrylic Acid
- Polyethylene Glycol (PEG)
- Others
Market Breakup by Application
- In Vitro
- In Vivo
Market Breakup by Substrate
- Tablets
- Capsules
- Pills
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global sustained release coatings market.Some of the major players explored in the report are as follows:
- BASF SE [BAS (ETR)]
- Evonik Industries AG [EVK (ETR)]
- Colorcon, Inc.
- Coating Place, Inc.
- Others
About the Analyst
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.These high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of these reports today.
The analyst always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope4 Key Assumptions7 Opportunities and Challenges in the Market15 Value Chain Analysis18 Key Trends and Developments in the Market
3 Report Description
5 Executive Summary
6 Snapshot
8 Global Sustained Release Coatings Market Analysis
9 North America Sustained Release Coatings Market Analysis
10 Europe Sustained Release Coatings Market Analysis
11 Asia Pacific Sustained Release Coatings Market Analysis
12 Latin America Sustained Release Coatings Market Analysis
13 Middle East and Africa Sustained Release Coatings Market Analysis
14 Market Dynamics
16 Price Analysis
17 Competitive Landscape
List of Key Figures and Tables
Companies Mentioned
- BASF SE [BAS (ETR)]
- Evonik Industries AG [EVK (ETR)]
- Colorcon Inc.
- Coating Place Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 156 |
Published | October 2023 |
Forecast Period | 2023 - 2028 |
Estimated Market Value ( USD | $ 0.57 Billion |
Forecasted Market Value ( USD | $ 0.78 Billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |
No. of Companies Mentioned | 4 |